Comparative study of midterm outcomes between Roux-en-Y gastric bypass (RYGB), diverted one-anastomosis gastric bypass (D-OAGB), and one anastomosis gastric bypass (OAGB) - Scorecard - MDSpire
Advertisement
Comparative study of midterm outcomes between Roux-en-Y gastric bypass (RYGB), diverted one-anastomosis gastric bypass (D-OAGB), and one anastomosis gastric bypass (OAGB)
Clinical Scorecard: Midterm Outcome Comparisons of Roux-en-Y Gastric Bypass, Diverted One-Anastomosis Gastric Bypass, and One-Anastomosis Gastric Bypass
At a Glance
Category
Detail
Condition
Obesity and obesity-related medical conditions
Key Mechanisms
Metabolic/bariatric surgery inducing weight loss and metabolic improvements via gastric bypass and intestinal bypass components
Target Population
Patients eligible for bariatric surgery per IFSO guidelines
Care Setting
Surgical bariatric centers with multidisciplinary evaluation
Key Highlights
Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB) are effective bariatric procedures with metabolic benefits.
OAGB offers a simpler surgical approach with potentially greater malabsorptive effects due to a longer biliopancreatic limb.
Diverted OAGB (D-OAGB) modifies OAGB by adding Roux-en-Y diversion to reduce bile reflux and marginal ulcers.
Guideline-Based Recommendations
Diagnosis
Patient eligibility for bariatric surgery should follow International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) guidelines.
GERD diagnosis postoperatively is based on typical symptoms and/or ongoing use of proton pump inhibitors beyond 3 months.
Management
Selection of bariatric procedure (RYGB, OAGB, or D-OAGB) should be individualized after patient-surgeon discussion of benefits and risks.
Surgical techniques include creation of gastric pouch and intestinal limb lengths specific to each procedure.
Intraoperative methylene blue test is recommended to detect anastomotic leakage.
Monitoring & Follow-up
Follow-up includes assessment of weight loss at 3, 6 months, and beyond using total weight loss percentage (TWL%) and excess weight loss percentage (EWL%).
Monitor improvement of obesity-related conditions by reduction or cessation of medications for hypertension, diabetes, and dyslipidemia.
Evaluate GERD symptoms and treatment status postoperatively to assess improvement or persistence.
Risks
Biliary reflux is a known complication of OAGB, potentially requiring surgical revision.
D-OAGB aims to reduce bile reflux risk by creating a Roux-en-Y configuration.
Perioperative adverse events should be monitored and managed accordingly.
Patient & Prescribing Data
Patients undergoing bariatric bypass surgeries (RYGB, OAGB, D-OAGB) with at least 2 years follow-up
Weight loss and metabolic improvements are achieved with all procedures; D-OAGB may reduce bile reflux complications compared to OAGB.
Clinical Best Practices
Ensure thorough preoperative multidisciplinary evaluation and informed consent discussing procedure-specific risks and benefits.
Use standardized surgical techniques with appropriate limb lengths and anastomosis methods to optimize outcomes.
Employ intraoperative leak testing to reduce postoperative complications.
Conduct regular postoperative follow-up to monitor weight loss, metabolic improvements, and GERD symptoms.
Consider D-OAGB as an alternative to OAGB to minimize bile reflux while maintaining weight loss efficacy.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.